Punishing pragmatism: The Tipline for 13 November 2023

Lina Khan, too conservative? The Wall Street Journal’s editorial team uses her as weekly cannon fodder and the defence bar whispers her name as though she is Lord Voldemort, but apparently she is still susceptible to criticism from the left. In a rare follow-up to a merger control action, Senator Elizabeth Warren says she is disappointed with the Federal Trade Commission’s decision to settle Amgen/Horizon Therapeutics.

Unlock unlimited access to all Global Competition Review content